Metabolic health
Menopause and type 2 diabetes risk
Estrogen supports insulin sensitivity. Its decline at menopause is one reason type 2 diabetes incidence rises in the 50s. HRT is not a diabetes treatment, but it modestly improves glucose control in most trials.
Metabolic changes at menopause
- Shift from subcutaneous to visceral fat
- Rising fasting insulin
- Worsening HDL and rising ApoB
- Sleep disruption further impairing glucose control
Frequently asked questions
Does HRT lower diabetes risk?
The WHI and HERS trials both showed a reduction in new-onset diabetes on HRT.
Can I take HRT with type 2 diabetes?
Yes, provided cardiovascular status is stable. Transdermal preferred.
What about GLP-1 agonists?
They complement HRT for weight and glucose control; the two are often used together.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.